These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 13130168)
41. [Observation of vasoactive intestinal polypeptide in patients with trigeminal neuralgia: a 16-cases report]. Zhao Y; Jiang X; Liu Y Hua Xi Kou Qiang Yi Xue Za Zhi; 2002 Feb; 20(1):33-4, 38. PubMed ID: 12593198 [TBL] [Abstract][Full Text] [Related]
42. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease. Mazumdar S; Das KM Am J Gastroenterol; 1992 Feb; 87(2):176-81. PubMed ID: 1370872 [TBL] [Abstract][Full Text] [Related]
43. [A preliminary study on substance P and vasoactive intestinal polypeptide contents in intestinal mucosa of chronic diarrhea with splenic weakness]. Zhang ZB Zhong Xi Yi Jie He Za Zhi; 1991 Mar; 11(3):144-6, 132. PubMed ID: 1712257 [TBL] [Abstract][Full Text] [Related]
44. Changes in ghrelin, substance P and vasoactive intestinal peptide levels in the gastroduodenal mucosa of patients with morbid obesity. Atas U; Erin N; Tazegul G; Elpek GO; Yildirim B Neuropeptides; 2021 Oct; 89():102164. PubMed ID: 34146741 [TBL] [Abstract][Full Text] [Related]
45. [The contribution of food and airborne allergens in the pathogenesis of atopic dermatitis]. Dynowska D; Kolarzyk E; Schlegel-Zawadzka M; Dynowski W Przegl Lek; 2002; 59(6):453-6. PubMed ID: 12418286 [TBL] [Abstract][Full Text] [Related]
47. Some neuropeptides as modulators of experimental contact allergy. Wallengren J; Möller H Contact Dermatitis; 1988 Nov; 19(5):351-4. PubMed ID: 2466607 [TBL] [Abstract][Full Text] [Related]
48. Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Anand P; Springall DR; Blank MA; Sellu D; Polak JM; Bloom SR Br J Dermatol; 1991 Jun; 124(6):547-9. PubMed ID: 1712221 [TBL] [Abstract][Full Text] [Related]
49. Regional content of enteric substance P and vasoactive intestinal peptide during intestinal inflammation in the parasitized ferret. Palmer JM; Greenwood B Neuropeptides; 1993 Aug; 25(2):95-103. PubMed ID: 7692345 [TBL] [Abstract][Full Text] [Related]
50. [Sleep disorders in childhood and adolescence, with special reference to allergic diseases]. Wasilewska J; Kaczmarski M; Protas PT; Kowalczuk-Krystoń M; Mazan B; Topczewska M Pol Merkur Lekarski; 2009 Mar; 26(153):188-93. PubMed ID: 19388530 [TBL] [Abstract][Full Text] [Related]
51. Distribution of vasoactive intestinal peptide- and substance P-containing nerves originating from neurons of airway ganglia in cat bronchi. Dey RD; Altemus JB; Michalkiewicz M J Comp Neurol; 1991 Feb; 304(2):330-40. PubMed ID: 1707900 [TBL] [Abstract][Full Text] [Related]
52. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study. Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381 [TBL] [Abstract][Full Text] [Related]
53. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide. Itoh H; Naito T; Takeyama M J Pharm Pharmacol; 2002 Nov; 54(11):1559-63. PubMed ID: 12495560 [TBL] [Abstract][Full Text] [Related]
54. Neurogenic markers of the inflammatory process in atopic dermatitis: relation to the severity and pruritus. Teresiak-Mikołajczak E; Czarnecka-Operacz M; Jenerowicz D; Silny W Postepy Dermatol Alergol; 2013 Oct; 30(5):286-92. PubMed ID: 24353488 [TBL] [Abstract][Full Text] [Related]
55. Substance P levels are decreased in lesional skin of atopic dermatitis. Fantini F; Pincelli C; Romualdi P; Donatini A; Giannetti A Exp Dermatol; 1992 Oct; 1(3):127-8. PubMed ID: 1285408 [TBL] [Abstract][Full Text] [Related]
56. Distribution of substance P and vasoactive intestinal peptide in the human liver: light and electron immunoperoxidase methods of observation. Ueno T; Inuzuka S; Torimura T; Sakata R; Sakamoto M; Gondo K; Aoki T; Tanikawa K; Tsutsumi V Am J Gastroenterol; 1991 Nov; 86(11):1633-7. PubMed ID: 1719804 [TBL] [Abstract][Full Text] [Related]
57. Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. Metwali A; Blum AM; Ferraris L; Klein JS; Fiocchi C; Weinstock JV J Neuroimmunol; 1994 Jun; 52(1):69-78. PubMed ID: 7515901 [TBL] [Abstract][Full Text] [Related]
58. Regulation of the peptidergic nerves (substance P and vasoactive intestinal peptide) in the colon of women patients with slow transit constipation: an in vitro study. Tomita R Hepatogastroenterology; 2008; 55(82-83):500-7. PubMed ID: 18613396 [TBL] [Abstract][Full Text] [Related]
59. Neuropeptide modulation of Th1 and Th2 cytokines in peripheral blood mononuclear leucocytes in atopic dermatitis and non-atopic controls. Gordon DJ; Ostlere LS; Holden CA Br J Dermatol; 1997 Dec; 137(6):921-7. PubMed ID: 9470908 [TBL] [Abstract][Full Text] [Related]
60. Parallel increase in substance P and VIP in rat duodenum in response to irradiation. Höckerfelt U; Franzén L; Kjörell U; Forsgren S Peptides; 2000 Feb; 21(2):271-81. PubMed ID: 10764956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]